Классические и новые аспекты папилломавирусной инфекции: ее влияние на репродуктивную функцию

1. Прилепская В.Н., ред. Заболевания шейки матки и генитальные инфекции. М.: ГЭОТАР-Медиа; 2016. 384с.

2. Назарова Н.М., Бурменская О.В., Суламанидзе Л.А., Прилепская В.Н., Павлович С.В., Трофимов Д.Ю. Распространенность типов вируса папилломы человека аногенитальной области у пациенток с ВПЧ-ассоциированными заболеваниями шейки матки. Акушерство и гинекология. 2015; 12: 89-96.

3. Bruni L., Barrionuevo-Rosas L., Albero G., Aldea M., Serrano B., Valencia S. et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2016- 02-25.

4. Дамиров М.М. Радиоволновые, криогенные и лазерные технологии в диагностике и лечении в гинекологии. М.: Издательство БИНОМ; 2011. 320с.

5. Роговская С.И. Практическая кольпоскопия. М.: ГЭОТАР-Медиа; 2011. 232с.

6. Роговская С.И., Липова Е.В., ред. Шейка матки, влагалище, вульва. Физиология, патология, кольпоскопия, эстетическая коррекция. Руководство для практикующих врачей. М.: Издательство журнала StatusPraesens; 2014. 832с.

7. Zhang L.D., Zhang H.M., Pei J., He G.R., Sun X.F., Li B. Investigation on HPV viral load and high risk HPV types infection among patients with infertility. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007; 21(2): 159-61.

8. van Hamont D., Nissen L.H., Siebers A.G., Hendriks J.C., Melchers W.J., Kremer J.A., Massuger L.F. Abnormal cervical cytology in women eligible for IVF. Hum. Reprod. 2006; 21(9): 2359-63.

9. Almobarak A.O., Elhoweris M.H., Nour H.M., Ahmed M.A., Omer A.F., Ahmed M.H. Frequency and patterns of abnormal Pap smears in Sudanese women with infertility: What are the perspectives? J. Cytol. 2013; 30(2): 100-3. doi: 10.4103/0970-9371.112651.

10. Nnadi D., Nwobodo E., Ekele B., Sahabi S. Screening for cervical cancer: a review of outcome among infertile women in a tertiary hospital in North-West Nigeria. Ann. Med. Health Sci. Res. 2014; 4(3): 383-7. doi: 10.4103/2141-9248.133464.

11. AbdullGaffar B., Kamal M.O., Hasoub A. The prevalence of abnormal cervical cytology in women with infertility. Diagn. Cytopathol. 2010; 38(11): 791-4.

12. Pereira N., Kucharczyk K.M., Estes J.L., Gerber R.S., Lekovich J.P., Elias R.T., Spandorfer S.D. Human papillomavirus infection, infertility, and assisted reproductive outcomes. J. Pathog. 2015; 2015: 578423. doi: 10.1155/2015/578423.

13. Foresta C., Noventa M., De Toni L., Gizzo S., Garolla A. HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal. Andrology. 2015; 3(2): 163-73. doi: 10.1111/andr.284.

14. Foresta C., Patassini C., Bertoldo A., Francavilla F., Barzon L., Ferlin A. Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. PLoS One. 2011; 6(3): e15036. doi: 10.1371/journal.pone.0015036.e15036.

15. Souho T., Benlemlih M., Bennani B. Human papillomavirus infection and fertility alteration: a systematic review. PLoS One. 2015; 10(5): e0126936. doi: 10.1371/journal.pone.0126936. eCollection 2015.

16. Zhang L., Hao Z.Y., Zhang X.S., Liang C.Z. Human papillomavirus sperm infection: a possible risk factor for male infertility. Asian J. Androl. 2014; 16(6): 929-30. doi: 10.4103/1008-682X.137682.

17. Gizzo S., Ferrari B., Noventa M., Ferrari E., Patrelli T.S., Gangemi M., Nardelli G.B. Male and couple fertility impairment due to HPV-DNA sperm infection: update on molecular mechanism and clinical impact – systematic review. Biomed. Res. Int. 2014; 2014: 230263. http://dx.doi.org/10.1155/2014/230263.

18. Foresta C., Pizzol D., Bertoldo A., Menegazzo M., Barzon L., Garolla A. Semen washing procedures do not eliminate human papilloma virus sperm infection in infertile patients. Fertil. Steril. 2011; 96(5): 1077-82. doi: 10.1016/j.fertnstert.2011.04.009.

19. Noventa M., Andrisani A., Gizzo S., Nardelli G.B., Ambrosini G. Is it time to shift the attention on early stages embryo development to avoid inconclusive evidence on HPV-related infertility: debate and proposal. Reprod. Biol. Endocrinol. 2014; 12: 48. doi: 10.1186/1477-7827-12-48.

20. Chen S.S., Block B.S., Chan P.J. Pentoxifylline attenuates HPV-16 associated necrosis in placental trophoblasts. Arch. Gynecol. Obstet. 2015; 291(3): 647-52. doi: 10.1007/s00404-014-3471-6.

21. Tolen J.A., Duerksen-Hughes P., Lau K., Chan P.J. Selenium attenuates HPV-18 associated apoptosis in embryo-derived trophoblastic cells but not inner cell mass in vitro. Int. J. Reprod. Med. 2015; 2015: 562567. doi: 10.1155/2015/562567.

22. Ambühl L.M., Baandrup U., Dybkær K., Blaakær J., Uldbjerg N., Sørensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infect. Dis. Obstet. Gynecol. 2016; 2016: 3086036. doi: 10.1155/2016/3086036.

23. Hong L.J., Oshiro B.T., Chan P.J. HPV-16 exposed mouse embryos: a potential model for pregnancy wastage. Arch. Gynecol. Obstet. 2013; 287(6): 1093-7. doi: 10.1007/s00404-013-2711-5.

24. Garolla A., Engl B., Pizzol D., Ghezzi M., Bertoldo A., Bottacin A. et al. Spontaneous fertility and in vitro fertilization outcome: new evidence of human papillomavirus sperm infection. Fertil. Steril. 2016; 105(1): 65-72. e1. doi: 10.1016/j.fertnstert.2015.09.018.

25. Garolla A., Lenzi A., Palù G., Pizzol D., Bertoldo A., De Toni L., Foresta C. Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution. Hum. Reprod. 2012; 27(4): 967-73. doi: 10.1093/humrep/des009.

26. Castle P.E., Maza M. Prophylactic HPV vaccination: past, present, and future. Epidemiol. Infect. 2016; 144(3): 449-68. doi: 10.1017/S0950268815002198.

27. Crosignani P., De Stefani A., Fara G.M., Isidori A.M., Lenzi A., Liverani C.A. et al. Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health. 2013; 13: 642. doi: 10.1186/1471-2458-13-642.

28. Depuydt C.E., Verstraete L., Berth M., Beert J., Bogers J.P., Salembier G. et al. Human papillomavirus positivity in women undergoing intrauterine insemination has a negative effect on pregnancy rates. Gynecol. Obstet. Invest. 2015; Jul 9.

29. Spandorfer S.D., Bongiovanni A.M., Fasioulotis S., Rosenwaks Z., Ledger W.J., Witkin S.S. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil. Steril. 2006; 86(3): 765-7.

30. Perino A., Giovannelli L., Schillaci R., Ruvolo G., Fiorentino F.P., Alimondi P. et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertil. Steril. 2011; 95(5): 1845-8. doi: 10.1016/j.fertnstert.2010.11.047.

31. Conde-Ferráez L., Chan May A.D.A., Carrillo-Martínez J.R., Ayora-Talavera G., González-Losa M.D.R. Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 170(2): 468-73. doi: 10.1016/j.ejogrb.2013.07.002.

32. Schillaci R., Capra G., Bellavia C., Ruvolo G., Scazzone C., Venezia R., Perino A. Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples. Fertil. Steril. 2013; 100(5): 1236-40. doi: 10.1016/j.fertnstert.2013.06.042.

33. Wang Y., Wang C., Qiao J., Wang L., Liang S. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer. Int. J. Gynecol. Obstet. 2008; 101(1): 21-6. doi: 10.1016/j.ijgo.2007.09.035.

34. Yang R., Wang Y., Qiao J., Liu P., Geng L., Guo Y.-L. Does human papillomavirus infection do harm to in-vitro fertilization outcomes and subsequent pregnancy outcomes? Chin. Med. J. 2013; 126(4): 683-7. doi: 10.3760/cma.j.issn.0366-6999.20121625.

35. Kyrgiou M., Athanasiou A., Paraskevaidi M., Mitra A., Kalliala I., Martin-Hirsch P. et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016; 354: i3633. doi: 10.1136/bmj.i3633.

36. Pinborg A., Ortoft G., Loft A., Rasmussen S.C., Ingerslev H.J. Cervical conization doubles the risk of preterm and very preterm birth in assisted reproductive technology twin pregnancies. Hum. Reprod. 2015; 30(1): 197-204. doi: 10.1093/humrep/deu260.

37. Heinonen A., Gissler M., Riska A., Paavonen J., Tapper A.M., Jakobsson M. Loop electrosurgical excision procedure and the risk for preterm delivery. Obstet. Gynecol. 2013; 121(5): 1063-8. doi: 10.1097/AOG.0b013e31828caa31.

38. Ciavattini A., Stortoni P., Mancioli F., Puglia D., Tranquilli A.L., Liverani C.A. The impact of loop electrosurgical excision procedure (LEEP) for CIN 2,3 on spontaneous preterm delivery in twin pregnancies by assisted reproductive technique: preliminary data. J. Matern. Fetal Neonatal Med. 2014; 27(11): 1169-71. doi: 10.3109/14767058.2013.850483.

39. Kyrgiou M., Valasoulis G., Stasinou S.M., Founta C., Athanasiou A., Bennett P., Paraskevadis E. Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes. Int. J. Gynaecol. Obstet. 2015; 128(2): 141-7. doi: 10.1016/j.ijgo.2014.07.038..

40. Khalid S., Dimitriou E., Conroy R., Paraskevaidis E., Kyrgiou M., Harrity C. et al. The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG. 2012; 119(6): 685-91. doi: 10.1111/j.1471-0528.2011.03252.x.

41. Berretta R., Gizzo S., Dall’Asta A., Mazzone E., Monica M., Franchi L. et al. Risk of preterm delivery associated with prior treatment of cervical precancerous lesion according to the depth of the cone. Dis. Markers. 2013; 35(6): 721-6. doi: 10.1155/2013/686027.

Поступила 13.01.2017

Принята в печать 17.02.2017